Wachtell, Lipton, Rosen & Katz and Maples and Calder represented Social Capital Suvretta Holdings Corp. I in the transaction. Goodwin Procter advised Akili, while Skadden, Arps,...
Social Capital Suvretta Holdings Corp. I’s Merger With Akili Interactive Labs
CSafe Global’s Acquisition of Softbox Systems
Goodwin Procter advised CSafe Global on the deal. CSafe Global, a portfolio company of Frazier Healthcare Partners and Thomas H. Lee Partners, announced the completion of its...
Sopra Steria’s Acquisition of Eva Group
IN BRIEF: ADVANT Altana, Coblence avocats, Goodwin Procter, advised on the matter. ADVANT Altana advised Sopra Steria Group with a team including Jean-Guy de Ruffray (IP&IT),...
Novo’s $90 Million Series B Preferred Stock Financing
Goodwin Procter advised Novo on the deal. Novo announced the completion of its $90 million Series B Preferred Stock financing that values the startup at $700 million....
Acadia Pharmaceuticals’ Collaboration Agreement with Stoke Therapeutics
Goodwin Procter advised Acadia Pharmaceutical on the deal while Wilson Sonsini represented Stoke Therapeutics. Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) announced its collaboration agreement with Stoke Therapeutics, Inc....
Dream Games’ $255 Million Series C Investment Round
Kinstellar and Orrick advised Dream Games on the deal while Goodwin Procter represented Index Ventures. Dream Games raised USD 255 million in a Series C investment round...
FountainVest Partners’ Acquisition of China F&B Group
Goodwin Procter advised FountainVest Partners on the deal. FountainVest Partners announced its acquisition of China F&B Group from EQT Partners. China F&B Group operates two renowned international...
Metaversal Ventures’ $50 Million Series A Financing Round
Goodwin Procter advised Metaversal Ventures on the deal. Metaversal Ventures, Inc. announced its $50 million Series A financing round. The round was co-led by CoinFund and Foxhaven...
York Private Equity and Cennox’s Acquisition of Mick’s Vault Works
Goodwin Procter advised York Private Equity and Lennox on the deal. York Capital Management’s private equity group (York Private Equity) and Cennox announced their acquisition of Mick’s...
Eluminex Biosciences’ Acquisition of Zuretinol Acetate Assets from Retinagenix
Goodwin Procter advised Eluminex Biosciences on the deal. Eluminex Biosciences (Suzhou) Limited (Eluminex) announced its acquisition of certain assets and the related global development and commercialization rights...
Permira’s Investment in BPL and Kedrion
Goodwin Procter advised Bio Products Laboratory and Tiancheng International Investment Limited on the deal. The shareholders of Kedrion was advised by Carnelutti and Pedersoli Studio Legale,...
Arrakis Therapeutics’ Collaboration Agreement with Amgen
Goodwin Procter advised Arrakis Therapeutics on the deal. Arrakis Therapeutics announced its research collaboration agreement with Amgen (NASDAQ:AMGN), focused on the discovery and development of RNA degrader...